Abstract 495: Discovery of BPI-221351, a potent, selective, orally available, and brain penetrating dual inhibitor of mutant IDH1/2
Shen, Hongling, Xu, Xiaofeng, Li, Yabin, Song, Xizhen, Chen, Jie, Bi, Yunting, Guo, Jing, Xu, Tong, Zhang, Huijuan, Liu, Lijia, Zou, Zhengyao, Ren, Jialin, Tong, Jun, Liu, Xiaoyun, Rong, Hongfei, Ma, Teng, Wang, Chao, Liu, Xiangyong, Chen, Hong, Zhao, Jiayu, Ju, Xuepeng, Chen, Haibo, Shen, Haidi, Lan, Hong, Ding, Lieming, Wang, Jiabing
Published in Cancer research (Chicago, Ill.) (04.04.2023)
Published in Cancer research (Chicago, Ill.) (04.04.2023)
Get full text
Journal Article